Search Results 1561-1570 of 14716 for anti-TNF drugs

  1. Factor Xiii (Intravenous Route) Description and Brand Names - Mayo Clinic

    Description and Brand Names. Drug information provided by: Merative, Micromedex®. US Brand Name. Corifact; Tretten. Descriptions. Factor ...

  2. Efficacy and Safety of REC-2282 in Participants with Progressive NF2 Mutated Meningiomas (POPLAR-NF2) - Mayo Clinic

    Drugs & Supplements A-Z · Health Books · Healthy ... By condition, treatment or drug name ... screening. 3. Received an anti- tumor agent for meningioma within 3 ...

  3. The Study of Nasal Insulin in the Fight Against Forgetfulness (SNIFF) - Mayo Clinic

    ... treatment (including both insulin dependent and non-insulin dependent diabetes mellitus); Current or past use of insulin or any other anti-diabetic medication ...

  4. LGX818 and MEK162 in Combination With a Third Agent (BKM120, LEE011, BGJ398 or INC280) in Advanced BRAF Melanoma - Mayo Clinic

    About this study. The primary purpose of this study is to assess the anti-tumor activity of LGX818/MEK162 in combination with targeted agents after ...

  5. Retrospective study finds that cancer drug also lowers blood glucose - Mayo Clinic News Network

    ROCHESTER, Minnesota — Dasatinib, a drug that often is used to treat certain types of leukemia, may have antidiabetic effects comparable to medications used ...

  6. Ado-Trastuzumab Emtansine (Intravenous Route) Description and Brand Names - Mayo Clinic

    It is also used as additional treatment in patients with HER2-positive early breast cancer who have cancer left after a taxane medicine and trastuzumab-based ...

  7. A Study to Evaluate the Safety and Effectiveness of RM-131 Administered to Patients with Vomiting Symptoms and Moderate to Severe Diabetes Caused Paralysis of the Stomach - Mayo Clinic

    Drugs & Supplements A-Z · Health Books · Healthy ... By condition, treatment or drug name. Search ... anti-emetics for at least 2 weeks prior to visit ...

  8. A Study of Using Lorvotuzumab Mertansine in Treating Younger Patients with Relapsed or Refractory Wilms Tumor, Rhabdomyosarcoma, Neuroblastoma, Pleuropulmonary Blastoma, Malignant Peripheral Nerve Sheath Tumor, or Synovial Sarcoma - Mayo Clinic

    The antibody is used to recognize tumor cells so the anti-cancer drug can kill them. Participation eligibility. Participant eligibility includes age, gender, ...

  9. Characterization of Circulating Tumor Cells (CTC) From Patients With Metastatic Breast Cancer Using the CTC-Endocrine Therapy Index - Mayo Clinic

    An algorithm for a CTC-Endocrine Therapy Index (CTC-ETI) has been constructed that can be calculated for each patient using the CTC enumeration and marker ...

  10. A Study to Investigate LYL797 in Adults With Solid Tumors - Mayo Clinic

    * Prior treatment with any adoptive T-cell therapy or anti-ROR1 therapy * Prior solid organ transplantation * Active, untreated brain metastasis or ...